Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 45 Breast Neoplasms 20 Myelodysplastic Syndromes 19 Prostatic Neoplasms 12 Neoplasms 12 Leukemia, Myelomonocytic, Chronic 12 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 9 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Multiple Myeloma 6 Esophageal Neoplasms 6 Myeloproliferative Disorders 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell 5 Lung Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Myelodysplastic-Myeloproliferative Diseases 4 Leukemia, Biphenotypic, Acute 4 Leukemia 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Neoplasms 4 Cholangiocarcinoma 4

Interventions

Infliximab 3 Fecal Microbiota Transplantation 3 vedolizumab 2 Prednisone 2 LDP-02 2 Immunoglobulin G 2 Disulfides 2 CT-P13 2 tocilizumab 1 prednylidene 1 fish oil triglycerides 1 deltacortene 1 Standard of Care 1 Practice Guidelines as Topic 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Loperamide 1 Injections 1 Endoscopy 1 Diagnosis 1 Colonoscopy 1 Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colitis × Injections × Clear all

NCT02814864 2021-08-03

PRISME

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡